Genetic Profile of Alpha Thalassemia Children at Sohag University Hospital .

NCT ID: NCT06591936

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-01

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Genetic profile of alpha thalassemia children at sohag university hospital ,the aim to determine the prevelance , molecular character of the disorder, characterized by decreased synthesis of alpha -globin Recent work to provide mechanisms for phenotypic heterogeneity .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alpha-Thalassemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

genetic of alpha thalathemia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acase suspecteed of alpha thalassemia
* age between 0-18years
* micocytic hypochromic anemia not iron deficiency anemia or Beta thalassemia

Exclusion Criteria

* Age more than 18 years
* healthy children free from any chronic hematological disease
* micocytic hypochromic anemia either iron deficiency anemia or Beta thalassemia
Minimum Eligible Age

0 Days

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marwa Mohamed Abdelrahim

Resedent doctor , pediatric and neonatology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sohag University Hospital

Sohag, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

marwa M abdelraheem, resedent doctor

Role: CONTACT

01152389379

alzahraa A Ahmed, professor

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

magdy M Amen, professor

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

soh-med-24-08-02MS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Thrombophilia In Beta Thalassemia
NCT04219449 NOT_YET_RECRUITING
EKLF Gene Expression in β-thalassemia
NCT06440603 NOT_YET_RECRUITING